Efficacy and safety of autologous hematopoietic stem cell transplantation (AHSCT) versus alemtuzumab in multiple sclerosis: Systematic review and individual patient data meta-analysis.

Lemtrada (alemtuzumab) - Sanofi

http://www.ncbi.nlm.nih.gov/pubmed/42735599

Elsayed S Moubarak; Huthaifah Ayman; Mohamed Emad Ali; Naima Kebir; Omar Fayez Abbas; Salem Waleed; Toka Aziz El-Ramly; Yousef A El Sayed

Sep 15, 2026